Hindustan Unilever Limited has informed the Exchange about Acquisition
HINDUNILVR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty 100 and 1.4 pts less than its Fast Moving Consumer Goods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Hindustan Unilever (HUL) has approved acquiring the remaining 49% stake in Zywie Ventures Private Limited (which runs the OZiva brand of vitamins, minerals, supplements, and protein products) for a cash consideration of Rs 824 crores. This will make Zywie and its subsidiary Zenherb Labs wholly owned subsidiaries of HUL. Zywie's turnover grew from Rs 100.07 crores in FY23 to Rs 257.67 crores in FY25, and the press release highlights OZiva scaling to about Rs 480 crores in 2025 with roughly 130% CAGR over the last two years. Separately, HUL's board has approved selling its 19.8% minority stake in Nutritionalab Private Limited (a joint venture with Rs 118.48 crores revenue in FY25) to USV Private Limited for Rs 307 crores. Both deals are expected to close by 31 March 2026, subject to closing conditions. The transactions align with HUL's stated strategy of 'fewer, bigger bets' in the fast-growing Health & Wellbeing category.
Positive strategic signal: HUL is consolidating full ownership of a high-growth wellness brand (OZiva) while pruning a minority non-core stake, reflecting sharper portfolio focus. Net cash outflow of roughly Rs 517 crores is modest relative to HUL's size and should not materially affect dividends or balance sheet strength, while giving investors fuller upside from the fast-growing OZiva brand going forward.